Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) EPS (Weighted Average and Diluted) (2022 - 2025)

Korro Bio's EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$5.32 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 135.4% year-over-year to -$5.32, compared with a TTM value of -$12.47 through Dec 2025, down 32.8%, and an annual FY2025 reading of -$12.48, down 33.19% over the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$5.32 at Korro Bio, down from -$1.92 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $147.86 in Q4 2023, with the low at -$225.59 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$21.52, with a median of -$2.46 recorded in 2024.
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 165.54% in 2023; the steepest drop was 11732.73% in 2023.
  • Tracing KRRO's EPS (Weighted Average and Diluted) over 4 years: stood at -$225.59 in 2022, then soared by 165.54% to $147.86 in 2023, then plummeted by 101.53% to -$2.26 in 2024, then crashed by 135.4% to -$5.32 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's EPS (Weighted Average and Diluted) are -$5.32 (Q4 2025), -$1.92 (Q3 2025), and -$2.74 (Q2 2025).